Skip to main content
Figure 2 | BMC Genomics

Figure 2

From: The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer

Figure 2

Alu Y subfamily enrichment. A: the number of selected loci in the sets P, O and S (see text). B: the percentage of the Alu Y subfamily out of the identified Alu elements in set E. C: the percentage of Alu elements in all cytosine loci and the percentage of the Alu Y subfamily in the identified Alu elements in either sliding windows of fixed size or extended size in RRBS in-silico simulation.

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us